Form D Explorer
TALPHERA, INC. · CIK 1427925

Report a data issueCitable research briefCompare issuerPrivate research collection

TALPHERA, INC.

CIK 1427925 · Corporation · Inc. DELAWARE · SAN MATEO, California · Pharmaceuticals
Sign up to follow Sign in for contact lookup
Filings
2
Original notices
2
Amendments
0
Activity
Apr 17, 2025
through Sep 15, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldApr 17, 2025 · DSep 15, 2025 · DLater minus earlier
Reported offering amount$15,000,000$28,969,997$13,969,997
Reported amount sold$4,920,000$16,984,999$12,064,999
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001427925-25-000001 · Later SEC source: 0001427925-25-000006

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Sep 15, 2025

Reported offering amount
$28,969,997
Reported exemptions
Rule 506(b)
Reported amount sold
$16,984,999

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)